Defeat Duchenne Canada Announce 2023-2024 Research Grants

Defeat Duchenne Canada, the country’s leader in Duchenne muscular dystrophy-funded research, is proud to announce that it will grant $880,320 toward five promising research projects this year – making the total awarded over its 29-year history $17.73M. The five new projects will enter a three-year agreement with the organization, joining six other research projects in years two and three of their funding.

 

Meet the researchers and hear the latest progress in Duchenne science.

Defeat Duchenne grant $17 million over 29-years to fund promising Duchenne research.

Read next...

2027 NMD4C-MDC Clinical Neuromuscular Fellowship Competition

Sixth Annual NMD4C and MDC Clinical Fellowship Competition from Opens May 1st

Together, NMD4C and MDC are excited to open our 2027 annual funding competition to provide clinical fellowship award(s) in neuromuscular medicine and electromyography (EMG)!  This annual funding competition provides one-year salary support ($80,000) for early-career clinicians to participate in Canadian neuromuscular medicine and EMG fellowship training programs.

04-2026 - Advancing Neuromuscular Research_ MDC Awards $700k to Seven NMD4C Investigator-Led Projects

Advancing Neuromuscular Research: MDC Awards $700k to Seven NMD4C Investigator-Led Projects

We’re proud to share that neuromuscular research led by our NMD4C Investigators and Leads; Dr. Hanns Lochmüller, Dr. Rashmi Kothary, Dr. Rami Massie, Dr. Elise Duchesne, Dr. Omid Kiamanesh, and Dr. Nicolas Dumont,  have been recognized in Muscular Dystrophy Canada’s 2026 Neuromuscular Clinical and Translational Research Grant announcement. Drawing from MDC’s national funding update, we’re…

2026 NMD4C Awards Recipients

Announcing the 2026 NMD4C Award Recipients

We are excited to announce the recipients of the 2026 NMD4C Awards, recognizing excellence, leadership, and impact across Canada’s neuromuscular research community. In this fourth cycle, the program introduces two new award categories, and expand on our ability to celebrate the work of contributions of trainees and patient partners who strengthen our national network.